BACKGROUND/AIMS: No study to date has systematically explored whether the Geriatric Depression Scale (GDS) measures symptoms of apathy and dysphoria in patients with Alzheimer's disease (AD) or related these constructs to cognitive and functional status. METHODS: Exploratory factor analysis (EFA) was used to identify factors of the GDS in a sample of 569 patients with probable AD. Two-way ANOVAs were used to determine the relationship of apathy and dysphoria to neuropsychological and functional measures. RESULTS: The EFA yielded four factors associated with apathy, dysphoria, social withdrawal and cognitive impairment. Apathy was associated with greater impairments in verbal memory, motor speed, and functional abilities. CONCLUSION: Apathy, but not dysphoria, was associated with some cognitive and functional variables. Results suggest that the GDS may be used as a screening measure for symptoms of apathy in AD.
BACKGROUND/AIMS: No study to date has systematically explored whether the Geriatric Depression Scale (GDS) measures symptoms of apathy and dysphoria in patients with Alzheimer's disease (AD) or related these constructs to cognitive and functional status. METHODS: Exploratory factor analysis (EFA) was used to identify factors of the GDS in a sample of 569 patients with probable AD. Two-way ANOVAs were used to determine the relationship of apathy and dysphoria to neuropsychological and functional measures. RESULTS: The EFA yielded four factors associated with apathy, dysphoria, social withdrawal and cognitive impairment. Apathy was associated with greater impairments in verbal memory, motor speed, and functional abilities. CONCLUSION: Apathy, but not dysphoria, was associated with some cognitive and functional variables. Results suggest that the GDS may be used as a screening measure for symptoms of apathy in AD.
Authors: S Christine You; Christine M Walsh; Louis A Chiodo; Robin Ketelle; Bruce L Miller; Joel H Kramer Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Huang Huang; Linmei Wang; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao Journal: Int J Neuropsychopharmacol Date: 2015-01-07 Impact factor: 5.176